SEC Filing Summary: Oculus Innovative Sciences, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on October 27, 2015, covering events occurring on October 22, 2015. The registrant is incorporated in Delaware with principal executive offices in Petaluma, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and capital structure amendments rather than financial performance.
Material Changes
- Authorized Share Increase: Effective October 22, 2015, the company filed a certificate of amendment with the Delaware Secretary of State to increase the total number of authorized common stock shares to 60,000,000.
- Stockholder Approval: The amendment to the Restated Certificate of Incorporation was approved by stockholders at the annual meeting.
- Share Details: The common stock has a par value of $0.0001 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the effective date and terms of the authorized share increase.
Investor Verification Checklist
- Verify the exact number of shares currently outstanding versus the new 60,000,000 authorized limit.
- Confirm the date and results of the annual meeting where stockholders approved the amendment.
- Review the attached Exhibit 3.1 (Certificate of Amendment) for any additional covenants or restrictions.
- Check subsequent filings for any immediate issuance of shares under the new authorization.